Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Synthetic genomics Stories

2014-04-02 08:32:55

Human Longevity and Synthetic Genomics Lease 125,300 Square Feet at 4570 Executive Drive SAN DIEGO, April 2, 2014 /PRNewswire/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced two expanding genomic research organizations co-founded by J. Craig Venter will fully occupy the 4570 Executive Drive property in University Towne Centre in San Diego, California. http://photos.prnewswire.com/prnvar/20091005/BIOMEDLOGO Synthetic Genomics Inc. (SGI) will lease approximately 69,700...

2014-02-28 16:23:58

LA JOLLA, Calif., Feb. 28, 2014 /PRNewswire-USNewswire/ -- The following is being released by the J. Craig Venter Institute: What: A telephonic media briefing hosted by J. Craig Venter, Ph.D., to announce a new genomic-based healthcare solution When: Tuesday, March 4, 2014 at 8:00 a.m. PT/11:00 a.m. ET Who: J. Craig Venter, Ph.D. and other co-founders, along with collaborating organizations Venter is Co-Founder, CEO and Chairman of the J. Craig Venter Institute, a not for profit...

2013-07-07 23:01:27

Transparency Market Research published new "Synthetic Biology Market - Global Industry Analysis, Size, Growth, Share And Forecast 2012 - 2018" market research report to its report store. Browse the report; visit http://www.transparencymarketresearch.com/synthetic-biology-market.html. Albany, New York (PRWEB) July 07, 2013 According to a new market report published by Transparency Market Research “Synthetic Biology Market, Global Industry Analysis, Size, Growth, Share and...

2013-05-16 12:32:57

Program will now focus on utilizing SGI expertise in synthetic genomics to enhance algae LA JOLLA, Calif., May 16, 2013 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company dedicated to developing genomic-driven solutions to address global challenges, today announced a new co-funded research agreement with ExxonMobil to develop algae biofuels. The new agreement is a basic science research program that focuses on developing algal strains with significantly improved...

2013-03-27 12:23:15

Preeminent Scientist Will Receive Honor at Annual Dinner on Sept. 4, 2013. KANSAS CITY, Mo., March 27, 2013 /PRNewswire-USNewswire/ -- The MRIGlobal Board of Directors and Trustees today announced that it will present its annual Citation Award this year to J. Craig Venter, Ph.D., one of the leading scientists of the 21(st) century. Dr. Venter is the Founder, Chairman, and Chief Executive Officer of the J. Craig Venter Institute, a not-for-profit research organization dedicated to human,...

2012-09-17 10:23:36

LA JOLLA, Calif., Sept. 17, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company developing and commercializing genomic-driven solutions to solve a range of global challenges, today announced they have purchased from Febit Holding GmbH the worldwide rights to three families of patents and patent applications related to key synthetic genomic technologies. All related know-how, equipment and technical support for implementation, were also purchased. This newly acquired...

2012-05-24 10:22:06

LA JOLLA, Calif., May 24, 2012 /PRNewswire/ -- Synthetic Genomics Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a range of global challenges, today announced they have purchased an 81 acre site for scale up and testing of newly identified and engineered algal strains. The company will use the site, located in the Imperial Valley near the Salton Sea, to test algal strains isolated by SGI or developed through SGI's proprietary synthetic...

2012-03-26 13:38:10

Just as aspiring authors often read hundreds of books before starting their own, scientists are using decades of knowledge garnered from sequencing or "reading" the genetic codes of thousands of living things to now start writing new volumes in the library of life. J. Craig Venter, Ph.D., one of the most renowned of those scientists, described the construction of the first synthetic cell and many new applications of this work today at the 243rd National Meeting & Exposition of the...

2012-02-07 16:00:00

LA JOLLA, Calif. and IPSWICH, Mass., Feb. 7, 2012 /PRNewswire/ -- Synthetic Genomics, Inc. (SGI), a privately held company commercializing and developing genomic-driven solutions to solve a variety of global needs, and New England Biolabs, Inc. (NEB), today jointly announced that they have entered into a non-exclusive licensing agreement whereby NEB will commercialize the Gibson Assembly(TM) Master Mix. This product is based on the Gibson Assembly(TM) method which was developed by Daniel...